Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2024-03-07 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
独立董事工作制度（2024年修订）
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, roles, responsibilities, nomination, election, and duties of independent directors within the company. It references relevant laws, regulations, and stock exchange rules, and outlines internal governance practices related to board composition and independent directors' functions. There is no financial data, earnings information, or report publication announcement. The content is focused on governance practices and internal rules regarding board members. Therefore, this document fits the category of Governance Information (CGR).
2024-03-07 Chinese
独立董事述职报告(陈凌)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2023, detailing the independent director's attendance, opinions, committee work, and efforts to protect investor rights. It is a narrative report on the director's duties and activities rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory filings. It is not an announcement of voting results or management changes. This type of document fits best under Board/Management Information (MANG) as it relates to board members' activities and governance roles.
2024-03-07 Chinese
独立董事述职报告(钱娟萍)
Board/Management Information Classification · 95% confidence The document is titled '2023 年度独立董事述职报告' which translates to '2023 Annual Independent Director's Work Report'. It details the independent director's attendance at board meetings, opinions on various company matters, committee work, and efforts to protect investor rights during the 2023 fiscal year. The content is a narrative report on the director's duties and activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. This type of document fits best under Board/Management Information (MANG) as it relates to the activities and responsibilities of a board member, specifically an independent director's report on their role and contributions during the year.
2024-03-07 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of various reports and proposals related to the 2023 annual report, financial statements, internal control evaluation, profit distribution plan, and other governance matters. It includes voting results and mentions that these matters will be submitted to the shareholders' meeting for approval. The document is short (1521 characters) and serves as an official announcement of meeting resolutions rather than the full annual report or financial statements themselves. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it a proxy solicitation or voting results declaration. It is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board meeting resolutions and approvals without containing the full reports or detailed financial data.
2024-03-07 Chinese
财务管理制度（2024年修订）
Governance Information Classification · 95% confidence The document is a detailed internal financial management system of a company, covering financial management policies, budgeting, cash and bank management, receivables, inventory, fixed assets, liabilities, cost and expense management, income and profit distribution, financial reporting, and accounting archives management. It is a comprehensive internal policy document rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, audit opinions, earnings data, or meeting materials. It is a governance-related document detailing internal rules and procedures for financial management and control within the company. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed procedural content, supporting this classification with high confidence.
2024-03-07 Chinese
未来三年（2024年–2026年）股东回报规划
Notice of Dividend Amount Classification · 85% confidence The document is a detailed plan outlining the company's shareholder return policy for the next three years (2024-2026), focusing on dividend distribution principles, methods, conditions, timing, and decision-making mechanisms. It references legal and regulatory frameworks and is issued by the company's board of directors. The content is about the company's dividend policy and shareholder return planning rather than an announcement of dividend amounts or payment dates. It is not a brief dividend notice but a comprehensive policy document. Therefore, it fits best under the category of Notice of Dividend Amount (DIV) since it deals with dividend planning and distribution details, which is the closest match among the categories provided.
2024-03-07 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.